MBIO:NASDAQ
Mustang Bio Inc
၀.၃၇ US$
arrow_downward
-၁.၇၈%(-၀.၀၀၆၇) 1D
၀.၃၇ US$
arrow_upward
+၀.၇၆% (+၀.၀၀၂၈)bedtimeAfter hours
Closed: အောက် ၁၄, GMT-၄ ၁၆:၀၀:၀၀ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MBIO...
Open
၀.၃၈ US$
High
၀.၄၃ US$
Low
၀.၃၇ US$
Mkt. cap
၂.၇၈ သန်း
Avg. vol.
၃.၃၂ သောင်း
Volume
၀.၀၀
52-wk high
၁.၆၉ US$
52-wk low
၀.၃၇ US$
EPS
-၀.၄၆ US$
Beta
၂.၀၉
Shares outstanding
၆.၇၃ သန်း
No. of employees
၄
Open
၀.၃၈ US$
High
၀.၄၃ US$
Low
၀.၃၇ US$
Mkt. cap
၂.၇၈ သန်း
Avg. vol.
၃.၃၂ သောင်း
Volume
၀.၀၀
52-wk high
၁.၆၉ US$
52-wk low
၀.၃၇ US$
EPS
-၀.၄၆ US$
Beta
၂.၀၉
Shares outstanding
၆.၇၃ သန်း
No. of employees
၄
News stories
From web sources and news partners
ad-hoc-news.de
·
ပြီးခဲ့သည့် ၁ ရက်
Mustang Bio stock sits 2.70 percent above its yearly low
Profile
Mustang Bio is an American clinical-stage biopharmaceutical company founded in 2015 and headquartered in Worcester, MA, U.S. Operating as a partner company of Fortress Biotech, Mustang Bio develops CAR-T immunotherapies and gene therapies for multiple diseases, including hematologic cancers, solid tumors, and X-linked severe combined immunodeficiency. Wikipedia
About Mustang Bio Inc
CEOManuel Litchman
Employees၄
Founded၂၀၁၅
HeadquartersWaltham, မက်ဆာချူးဆက်ပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Websitemustangbio.com